The evolution of surgical treatment for gastrointestinal cancers Yoshihiko MaeharaYuji SoejimaMasaki Mori Special Article 14 September 2019 Pages: 1333 - 1349
PLEKHG5 is a novel prognostic biomarker in glioma patients Mingyu QianZihang ChenGang Li Original Article 15 July 2019 Pages: 1350 - 1358
Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study Yanling FanYanfang DuHaiyong Wang Original Article 10 June 2019 Pages: 1359 - 1366
Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial Junichi SohShinichi ToyookaHiroshi Date Original Article 16 July 2019 Pages: 1367 - 1376
Efficacy of chemotherapy for older patients with gastric cancer: a multicenter retrospective cohort study Yoshito HayashiTsutomu NishidaTetsuo Takehara Original Article 25 July 2019 Pages: 1377 - 1384
Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis Masayoshi HosakaIchiro AraiYoshiharu Motoo Original Article 12 July 2019 Pages: 1385 - 1396
Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials Kosuke HiroseEiji OkiMasaki Mori Original Article 22 July 2019 Pages: 1397 - 1405
Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancer Giuseppe A. CollocaAntonella VenturinoDomenico Guarneri Original Article 09 July 2019 Pages: 1406 - 1411
Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study Yasukiyo MurakamiKazumasa MatsumotoMasatsugu Iwamura Original Article 13 June 2019 Pages: 1412 - 1418
The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas Stylianos VagiosPetros YiannouKitty Pavlakis Original Article 13 June 2019 Pages: 1419 - 1428
Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer Doo Byung ChayGwan Hee HanStephen M. Hewitt Original Article 13 July 2019 Pages: 1429 - 1439
Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study Lei LiMing WuSen Zhong Original Article 15 July 2019 Pages: 1440 - 1448
Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study Ikuyo TsutsumiSusumu KunisawaYuichi Imanaka Original Article 12 July 2019 Pages: 1449 - 1458
Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database Jun ZhangZhenyu PanJun Lyu Original Article 26 June 2019 Pages: 1459 - 1467
Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors Yosuke HondaHirohisa KatagiriKen Yamaguchi Original Article 01 July 2019 Pages: 1468 - 1478
CDC20 and its downstream genes: potential prognosis factors of osteosarcoma Man-si WuQing-yu MaJia-xu Chen Original Article 05 July 2019 Pages: 1479 - 1489
Clinical results of carbon-ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas Yoshihiro MatsumotoAkira MatsunobuYasuharu Nakashima Original Article 06 July 2019 Pages: 1490 - 1497
Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan Yoshihiro NishidaAkira KawaiToshifumi Ozaki Original Article 22 July 2019 Pages: 1498 - 1505
